Discontinued — last reported Q1 '25
Thermo Fisher Scientific Income Tax at U.S. Statutory Rate increased by 7.1% to $364.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $340.00M to $364.00M.
Used as a benchmark to evaluate the effectiveness of the company's tax planning and the impact of various tax incentives.
The theoretical income tax expense calculated by applying the standard federal statutory tax rate to the company's pre-t...
Standard baseline metric in tax rate reconciliations for all public companies.
is_cat_income_tax_at_statutory_rate| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $430.00M | $456.00M | $533.00M | $403.00M | $336.00M | $286.00M | $301.00M | $370.00M | $334.00M | $370.00M | $366.00M | $340.00M | $364.00M |
| QoQ Change | — | +6.0% | +16.9% | -24.4% | -16.6% | -14.9% | +5.2% | +22.9% | -9.7% | +10.8% | -1.1% | -7.1% | +7.1% |
| YoY Change | — | — | — | -6.3% | -26.3% | -46.3% | -25.3% | +10.1% | +16.8% | +22.9% | -1.1% | +1.8% | +7.1% |